4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-004373
Options or other derivatives
- Chief Business & Strgy Officer acquired 1,918,392 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/tm231655-13_4seq1.xml…